AVE 0.00% 0.3¢ avecho biotechnology limited

transdermal patch, page-3

  1. 10,009 Posts.
    "Has the potential to be a substabtial commerical success for POH" and a huge windfall for its shareholders. That phrase says it all. They have a well known approved drug which they can put in a patch and sell into a US $1.5 bn market. This will be really easy to get thru FDA and very quick also. This is a very important announcement it show we are on the way to big dollar markets here. With several compounds ready to roll. And hundreds more that can be easily partnered out. Every big pharma going will be wanting to sleep with POH. They can then repatent all their blockbuster drugs.

    It is amazing PRR can attract so much interest whilst this company goes totally unnoticed.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.32K 440K

Buyers (Bids)

No. Vol. Price($)
30 40522233 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 40065430 31
View Market Depth
Last trade - 14.05pm 15/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.